Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

Telfer, Paul; Coen, Pietro G; Christou, Soteroula; Hadjigavriel, Michael; Kolnakou, Anita; Pangalou, Evangelia; Pavlides, Nicos; Psiloines, Michael; Simamonian, Krikor; Skordos, Georghios; Sitarou, Maria; Angastiniotis, Michael

Telfer, Paul; Coen, Pietro G; Christou, Soteroula; Hadjigavriel, Michael; Kolnakou, Anita; Pangalou, Evangelia; Pavlides, Nicos; Psiloines, Michael; Simamonian, Krikor; Skordos, Georghios; Sitarou, Maria; Angastiniotis, Michael.

Affiliation

Telfer P; Department of Paediatric Haematology and Oncology, St. Bartholomew's and The Royal London Hospitals NHS Trust, UK. paul.telfer@bartsandthelondon.nhs.uk

Haematologica ; 91(9): 1187-92, 2006 Sep.

Article in En | MEDLINE | ID: mdl-16956817

Subject(s)

Thalassemia/drug therapy; Thalassemia/epidemiology; Cyprus/epidemiology; Deferiprone; Deferoxamine/therapeutic use; Drug Therapy, Combination; Female; Humans; Iron Chelating Agents/therapeutic use; Male; Pyridones/therapeutic use; Retrospective Studies; Risk Factors; Survival Rate; Thalassemia/mortality

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thalassemia Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Haematologica Year: 2006 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links